NCT04642131

Brief Summary

Several studies have shown the positive effect that caffeine has on athletic performance related variables. Nonetheless, most studies have been developed in males and have not studied the possible effects on biomechanics and related injuries. Moreover, the inclusion of personalized insoles could also affect biomechanical patterns and thus injury incidence that has shown to be higher when athletes are fatigued. Therefore, the aim of the present randomized controlled trial is to evaluate the effect of fatigue, caffeine supplementation and personalized insoles on biomechanics and athletic performance in female adult soccer players.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 24, 2020

Completed
15 days until next milestone

Study Start

First participant enrolled

December 9, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

3.6 years

First QC Date

November 6, 2020

Last Update Submit

May 6, 2024

Conditions

Keywords

womeninsoleskinematicskineticsperformanceathleticsteam sport

Outcome Measures

Primary Outcomes (27)

  • Agility after fatigue and caffeine supplementation

    Assessment of agility in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    One day

  • Jump height after fatigue and caffeine supplementation

    Assessment of jump height in centimetres before and after a fatigue protocol is applied. Data will be collected with force plates.

    One day

  • Repeated sprint ability after fatigue and caffeine supplementation

    Assessment of repeated sprints ability in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    One day

  • Agility after fatigue and personalized insoles

    Assessment of agility in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    One day

  • Jump height after fatigue and personalized insoles

    Assessment of jump height in centimetres before and after a fatigue protocol is applied. Data will be collected with force plates.

    One day

  • Repeated sprint ability after fatigue and personalized insoles

    Assessment of repeated sprints ability in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    One day

  • Agility after fatigue and placebo

    Assessment of agility in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    One day

  • Jump height after fatigue and placebo

    Assessment of jump height in centimetres before and after a fatigue protocol is applied. Data will be collected with force plates.

    One day

  • Repeated sprint ability after fatigue and placebo

    Assessment of repeated sprints ability in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    One day

  • Hip range of motion after fatigue and caffeine supplementation

    Assessment of hip range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Knee range of motion after fatigue and caffeine supplementation

    Assessment of knee range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Ankle range of motion after fatigue and caffeine supplementation

    Assessment of ankle range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Hip flexion moment after fatigue and caffeine supplementation

    Assessment of hip flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Knee flexion moment after fatigue and caffeine supplementation

    Assessment of knee flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Ankle flexion moment after fatigue and caffeine supplementation

    Assessment of ankle flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Hip range of motion after fatigue and personalized insoles

    Assessment of hip range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Knee range of motion after fatigue and personalized insoles

    Assessment of knee range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Ankle range of motion after fatigue and personalized insoles

    Assessment of ankle range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Hip flexion moment after fatigue and personalized insoles

    Assessment of hip flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Knee flexion moment after fatigue and personalized insoles

    Assessment of knee flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Ankle flexion moment after fatigue and personalized insoles

    Assessment of ankle flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Hip range of motion after fatigue and placebo

    Assessment of hip range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Knee range of motion after fatigue and placebo

    Assessment of knee range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Ankle range of motion after fatigue and placebo

    Assessment of ankle range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Hip flexion moment after fatigue and placebo

    Assessment of hip flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Knee flexion moment after fatigue and placebo

    Assessment of knee flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

  • Ankle flexion moment after fatigue and placebo

    Assessment of ankle flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    During the intervention

Secondary Outcomes (4)

  • Injury incidence

    Six months

  • Sleep disturbances after caffeine ingestion

    Immediately after the intervention

  • Sleep disturbances after personalized insoles

    Immediately after the intervention

  • Sleep disturbances after placebo

    Immediately after the intervention

Study Arms (3)

Personalized insoles

EXPERIMENTAL

Personalized insoles without supplementation

Device: Personalized insoles

Caffeine supplementation

EXPERIMENTAL

Standard insoles with caffeine supplementation (3mg/kg)

Dietary Supplement: Caffeine supplementation

Control condition

PLACEBO COMPARATOR

Standard insoles without supplementation

Other: Control condition

Interventions

Caffeine supplementationDIETARY_SUPPLEMENT

Participants will wear standard insoles and ingest caffeine in liquid form (3mg/kg) with carbohydrates.

Caffeine supplementation

Participants will wear personalized insoles and ingest a drink of carbohydrates without caffeine

Personalized insoles

Participants will wear standard insoles and ingest a drink of carbohydrates without caffeine

Control condition

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females
  • Soccer players who have been competing for at least 3 years

You may not qualify if:

  • Participants with major injuries in the lower limbs within the 12 months before testing.
  • Participants consuming ephedrine or related medicines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Zaragoza

Zaragoza, 50012, Spain

Location

MeSH Terms

Conditions

FatigueWounds and InjuriesDisorder of Sex Development, 46,XY

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsDisorders of Sex DevelopmentUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGonadal DisordersEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants will be given a bottle with either caffeine and carbohydrates or just carbohydrates.
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Participants will be given a bottle with either caffeine and carbohydrates or just carbohydrates, and personalized insoles or standard insoles. All participants will complete athletic and biomechanics tests before and after completing a 43 minute fatigue protocol.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 6, 2020

First Posted

November 24, 2020

Study Start

December 9, 2020

Primary Completion

July 1, 2024

Study Completion

December 31, 2025

Last Updated

May 8, 2024

Record last verified: 2024-05

Locations